FIFTH THIRD BANCORP - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 206 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIFTH THIRD BANCORP ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$1,188,692
-31.2%
74,108
-0.5%
0.01%
-25.0%
Q2 2023$1,726,771
+7.5%
74,494
+7.7%
0.01%
+14.3%
Q1 2023$1,606,819
+66.9%
69,170
+4.3%
0.01%
+40.0%
Q4 2022$962,521
-13.8%
66,335
+13.4%
0.01%
-16.7%
Q3 2022$1,116,000
+145.8%
58,500
+134.4%
0.01%
+200.0%
Q2 2022$454,000
-17.5%
24,961
+14.4%
0.00%0.0%
Q1 2022$550,000
+17.0%
21,819
+28.2%
0.00%0.0%
Q4 2021$470,000
+4.2%
17,024
+21.9%
0.00%0.0%
Q3 2021$451,000
+33.4%
13,968
+26.3%
0.00%
+100.0%
Q2 2021$338,000
-12.0%
11,059
-12.3%
0.00%
-50.0%
Q1 2021$384,000
+67.0%
12,614
+8.5%
0.00%
+100.0%
Q4 2020$230,000
+139.6%
11,627
+58.7%
0.00%0.0%
Q3 2020$96,000
+20.0%
7,325
+4.2%
0.00%
Q2 2020$80,000
+70.2%
7,030
+112.1%
0.00%
Q1 2020$47,000
+1466.7%
3,315
+3542.9%
0.00%
Q2 2016$3,0000.0%910.0%0.00%
Q1 2016$3,000
-25.0%
910.0%0.00%
Q4 2015$4,000
+33.3%
910.0%0.00%
Q3 2015$3,0000.0%910.0%0.00%
Q2 2015$3,000
-70.0%
91
-67.3%
0.00%
Q1 2015$10,000
+11.1%
2780.0%0.00%
Q4 2014$9,000
-59.1%
278
-50.3%
0.00%
Q3 2014$22,000
-46.3%
559
-47.4%
0.00%
Q2 2014$41,000
-86.3%
1,063
-87.9%
0.00%
-100.0%
Q1 2014$299,000
-72.9%
8,751
-83.4%
0.00%
-72.7%
Q4 2013$1,103,000
+43.1%
52,568
+60.3%
0.01%
+37.5%
Q3 2013$771,000
-15.3%
32,794
-3.2%
0.01%
-20.0%
Q2 2013$910,00033,8720.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders